Latest Articles

The Magic Fit of Oncology Nursing
BY FRED HARDWICKE, M.D. HEMATOLOGY/MEDICAL ONCOLOGY FELLOWSHIP PROGRAM DIRECTOR, TEXAS TECH MEDICAL CENTER ó DEPARTMENT OF INTERNAL MEDICINE
An Extraordinary Healer essay honoring SEONG-HEE CHEON, RN, OCN [SOUTHWEST CANCER CENTER, LUBBOCK, TEXAS]
My Charge Nurse, Teacher, Mentor, Co-Worker and Friend
BY GEOVANNY GOMEZ, CNA PROVIDENCE ST. JOHNíS HEALTH CENTER, SANTA MONICA, CALIFORNIA
An Extraordinary Healer essay honoring LIDICE CEA, LVN [CANCER CENTER AND BREAST CENTER OU
Patients with Lung Cancer Have Risk of Cancer-Associated Suicide
BY ALLIE CASEY
The rate of patients with lung cancer who commit suicide is higher than those with other types of tumors. A recent study examined why.
Stem Cell Transplantation Reaches More Populations
BY GINA COLUMBUS
Over the years, stem cell transplantation has drastically involved, not only moving into different types of hematologic malignancies, but also into patient populations of different ethnicities, says Tsiporah B. Shore, M.D.
 
Examining Age-Specific Breast and Ovarian Cancer Risk Among BRCA Carriers
BY KATIE KOSKO
A recent study examined how age plays a factor in cancer risk for women with the BRCA1 or BRCA2 genetic mutation.
Combination Approved for BRAF-Positive Lung Cancer
BY JASON HARRIS
The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) gained approval from the Food and Drug Administration (FDA) for the treatment of patients with BRAF V600–positive advanced or metastatic non–small cell lung cancer (NSCLC).
FDA Approves Rituxan Hycela for Blood Cancers
BY JASON M. BRODERICK
Rituxan Hycela (rituximab) was granted approval by the Food and Drug Administration (FDA) for adult patients with previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL) and previously untreated and previously treated chronic lymphocytic leukemia (CLL).
Senate Releases Plan for Repealing Affordable Care Act, as Cancer Advocates Weigh In
BY ALLIE CASEY
This morning, Senate Republican leaders released the draft of a bill to repeal and replace the Affordable Care Act (Obamacare).
 
Drug Resistance Mediated by Gene Expression in Prostate Cancer
BY ARIELA KATZ
Inhibiting the ABCB1  gene with antiandrogen therapy – such as Xtandi (enzalutamide) and Casodex (bicalutamide) – may be the answer to increasing efficiency of tanxane-based therapies.
x